Increasing access to HIV treatment in middle-income countries: Key data on prices, regulatory status, tariffs and the intellectual property situation

The paper provides information on the prices paid by 20 middle-income countries for adult and paediatric formulations of antiretroviral treatments recommended by WHO. It links this information with an analysis of the intellectual property situation of the selected medicines taking into account existing license agreements as well as compulsory licenses, and includes data and general information on a number of other determinants of prices and availability of ARVs, including tariffs, markups and taxes, as well as the regulatory status.

Planning & Budgeting, Policy, Pricing, Procurement, Selection

  • Sub-categories HIV/AIDS
  • Commodities Medicines
  • Latest update May 2014
  • Version
  • Developed by WHO
  • When to use The paper provides information on the prices paid by 20 middle-income countries for adult and paediatric formulations of antiretroviral treatments recommended by WHO. It links this information with an analysis of the intellectual property situation of the selected medicines taking into account existing license agreements as well as compulsory licenses, and includes data and general information on a number of other determinants of prices and availability of ARVs, including tariffs, markups and taxes, as well as the regulatory status.
  • Languages English
  • Level of use Central
  • Form pdf file
  • Amount of training / TA required n/a
  • Inputs & outputs n/a
  • Cost Free
  • Advantages n/a
  • Limitations n/a
  • Availability http://www.who.int/phi/publications/WHO_Increasing_access_to_HIV_treatment.pdf?ua=1
  • Remarks HIV/AIDS Department, World Health Organization
  • Contact amds@who.int
  • Submission date 2014-07-05 19:13:47